Anna Lundén talks about tendencies and developments to be found in observations and warning letters from mhra Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
Description: Tendencies and developments to be found in observations and warning letters.nnNon-compliance issues tend to be on computerised systems and especially within issues on data integrity. This eventually documents, that regulatory authorities now are looking for e.g. data integrity non-compliance issues.nnMedicines and Healthcare Products Regulatory Agency in the UK (MHRA) has published a GMP Data Integrity guideline (March 2015)